Skip to content

Research for insulin intensive therapy in patients with liver cirrhosis with diabetes mellitus

Research for insulin intensive therapy in patients with liver cirrhosis with diabetes mellitus

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019252
Enrollment
Unknown
Registered
2018-11-01
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cirrhosis

Interventions

Compensatory liver cirrhosis patients:Insulin intensive therapy
Decompensatory liver cirrhosis patients: Insulin intensive therapy

Sponsors

Beijing YouAn Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with cirrhosis, men and women and causes are not limited; 2. Aged 18-65 years old; 3. The diagnosis of cirrhosis conforms to the 2015 version of the chronic hepatitis B prevention and treatment guidelines, and the diagnosis of diabetes conforms to the 2017 version of China's type 2 diabetes prevention and treatment guidelines; 4. According to the guidelines for the prevention and treatment of type 2 diabetes, insulin intensive treatment is required: glycosylated hemoglobin HbA1C = 9.0 % or fasting blood sugar = 11.1 mmol/L. 5. Can cooperate with monitoring and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Combined with acute gastrointestinal bleeding, hepatic encephalopathy above II degree, coma, etc; 2. Long-term use of glucocorticoids; 3. Concurrency with chronic renal failure; 4. Unable to cooperate with the monitoring follow-up and refused to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
Fasting blood sugar;

Secondary

MeasureTime frame
Cytofactors;

Countries

China

Contacts

Public ContactZhao Juan

Beijing YouAn Hospital, Capital Medical University

zhaojuanof241@163.com+86 13810426328

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026